tiprankstipranks
Trending News
More News >
Danone SA ADR (DANOY)
OTHER OTC:DANOY
US Market

Danone SA (DANOY) Earnings Dates, Call Summary & Reports

Compare
187 Followers

Earnings Data

Report Date
Jul 29, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
0.37
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 20, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a predominately positive operational and financial performance for FY25: like-for-like sales growth (+4.5%), margin expansion (+44 bps to 13.4%), EPS growth (+4.6% to EUR 3.80), strong free cash flow (EUR 2.8bn) and improved ROIC (10.7%). Strategic highlights included platform scale-ups (Oikos PRO, Alpro), Medical Nutrition M&A (Kate Farms ~ $500m), sustainability milestones (B Corp, CDP Triple A) and supply-chain recognition. Against this backdrop, notable near-term challenges were the Infant Milk Formula recalls (estimated one-off Q1 sales impact ~0.5%–1.0%), North American underperformance, currency headwinds and some H2 margin phasing pressures from ingredient inflation. Management framed these as addressable (targeted investments, leadership changes, capacity expansion and confidence in FY26 guidance). Overall, positives (broad-based growth, cash generation, strategic milestones) outweigh the lowlights, which are significant but largely short- to medium-term in nature.
Company Guidance
Danone guided 2026 net sales like‑for‑like growth of +3% to +5% with recurring operating income expected to grow faster than sales, while flagging a one‑off Q1 sales headwind of ~0.5–1.0% (50–100 bps) from Infant Milk Formula recalls that management expects to normalize through March; they expect North America recovery to pick up from Q2 (easier coffee‑creamer comps) and plan to include Kate Farms in like‑for‑like from Q3. Capital deployment will modestly step up to support capacity (CapEx around 4–4.5% of sales), the board will propose a dividend of EUR 2.25 per share (~+5%), and management reiterated the ambition to keep ROIC sustainably in double‑digit territory (ROIC was 10.7% in 2025). This guidance is set against FY25 results of +4.5% LFL sales (volume/mix +2.7%, price +1.8%), recurring operating margin up 44 bps to 13.4%, recurring EPS EUR 3.80 (+4.6%), and EUR 2.8bn free cash flow.
Solid Like-for-Like Sales Growth
Full-year like-for-like sales grew +4.5% (Q4 +4.7%), driven by volume/mix (+2.7% FY; +2.5% Q4) and price (+1.8% FY; +2.1% Q4). Reported sales were broadly stable at EUR 27.3bn after currency and scope effects.
Improved Profitability and EPS
Recurring operating margin expanded by +44 basis points to 13.4% and recurring EPS rose +4.6% to EUR 3.80, close to an all-time high.
Strong Cash Generation and ROIC
Free cash flow of EUR 2.8 billion for 2025 and Return on Invested Capital improved to double-digit (10.7%), up ~62 basis points year-on-year.
Category and Platform Momentum
Specialized Nutrition grew +7.4% like-for-like; EDP +3.5%; Waters +1.9%. High-protein platforms performed strongly globally (Oikos PRO exceeded EUR 1bn), Alpro became a EUR 1bn platform, and Fortimel/Nutrison Medical Nutrition reached ~EUR 1bn.
Regional Standouts — CNAO and Emerging Markets
China, North Asia & Oceania (CNAO) delivered exceptional LFL growth of +11.7%, driven by volume (+12%). Latin America grew +6% LFL and AMEA +5.6% LFL, all finishing the year strongly.
Strategic M&A and Portfolio Moves
Acquisition of Kate Farms helped build a US Medical Nutrition platform (~$500m) and an additional 1% stake in Australian JV raised ownership to 51% (financial consolidation). Integration and scale gains already showing strong growth for Kate Farms.
Sustainability & Operations Recognition
Worldwide B Corp certification achieved; CDP Triple A recognition retained. Supply chain ranked 10th in Gartner Top 25 Supply Chains; Industry 5.0 Academy upskilling 20,000 employees and 10 factories piloting digital factory capabilities.
Dividend Increase
Proposed dividend of EUR 2.25 per share, up ~5% versus prior year, aligned with EPS growth.

Danone SA (DANOY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DANOY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 29, 2026
2026 (Q2)
- / -
0.371
Feb 20, 2026
2025 (Q4)
0.44 / 0.45
0.38914.65% (+0.06)
Jul 30, 2025
2025 (Q2)
0.42 / 0.37
0.39-5.13% (-0.02)
Feb 26, 2025
2024 (Q4)
0.37 / 0.39
0.3870.52% (<+0.01)
Jul 31, 2024
2024 (Q2)
0.37 / 0.39
0.93-58.06% (-0.54)
Feb 22, 2024
2023 (Q4)
0.38 / 0.39
0.3811.57% (<+0.01)
Jul 26, 2023
2023 (Q2)
0.37 / 0.93
0.33181.82% (+0.60)
Feb 22, 2023
2022 (Q4)
0.35 / 0.38
0.396-3.79% (-0.02)
Jul 27, 2022
2022 (Q2)
0.34 / 0.33
0.364-9.34% (-0.03)
Feb 23, 2022
2021 (Q4)
0.37 / 0.40
0.403-1.74% (>-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DANOY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 20, 2026
$17.39$17.31-0.46%
Jul 30, 2025
$15.26$16.20+6.19%
Feb 26, 2025
$14.57$14.30-1.85%
Jul 31, 2024
$12.77$13.04+2.11%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Danone SA ADR (DANOY) report earnings?
Danone SA ADR (DANOY) is schdueled to report earning on Jul 29, 2026, Before Open (Confirmed).
    What is Danone SA ADR (DANOY) earnings time?
    Danone SA ADR (DANOY) earnings time is at Jul 29, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DANOY EPS forecast?
          Currently, no data Available